There was also a 12 percent higher rate of gout for people on GLP-1s
The live webinar will be held on Wednesday, November 12, 2025 , tailored to the services provided by the provider types below: This webinar will provide a comprehensive review of our administrative services and processes, including: Registration Details To register, please visit hpplans.com/webinars
Key Takeaways GLP-1 receptor agonists, including Tirzepatide, Semaglutide, and Liraglutide, are effective in promoting weight loss and improving glycemic control, with varying degrees of effectiveness and administration schedules
Never dispose of needles in household waste, as this poses a risk to others
A calm routine starts with the medication being stored and prepared correctly, not rushed at the last minute
It has been reported that there is no reduction in its secretion in patients with T2DM [13] but a nearly total loss of insulinotropic effect is observed, even at supraphysiological concentrations, implying the existence of GIP resistance [14]
